YALÇIN, A. D. Et Al. 2011. Serum soluble TRAIL levels in patients with severe persistent allergic asthma its relation to Omalizumab treatment. 16th Congress of Asian Pasific Society of Respirology .

YALÇIN, A. D., BİŞGİN, A., KARGI, A., & Gorczynski, R., (2011). Serum soluble TRAIL levels in patients with severe persistent allergic asthma its relation to Omalizumab treatment . 16th Congress of Asian Pasific Society of Respirology

YALÇIN, ARZU Et Al. "Serum soluble TRAIL levels in patients with severe persistent allergic asthma its relation to Omalizumab treatment," 16th Congress of Asian Pasific Society of Respirology, 2011

YALÇIN, ARZU D. Et Al. "Serum soluble TRAIL levels in patients with severe persistent allergic asthma its relation to Omalizumab treatment." 16th Congress of Asian Pasific Society of Respirology , 2011

YALÇIN, A. D. Et Al. (2011) . "Serum soluble TRAIL levels in patients with severe persistent allergic asthma its relation to Omalizumab treatment." 16th Congress of Asian Pasific Society of Respirology .

@conferencepaper{conferencepaper, author={ARZU DİDEM YALÇIN Et Al. }, title={Serum soluble TRAIL levels in patients with severe persistent allergic asthma its relation to Omalizumab treatment}, congress name={16th Congress of Asian Pasific Society of Respirology}, city={}, country={}, year={2011}}